Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and ...

Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).